Loading: 100%
EXACT SCIENCES CORP logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter , , no data available
Employees 736 (as per Q2 2017)no data available
Sector Medical Diagnostics & Research, HealthcareMedical Diagnostics & Research, Healthcareno data available
Ticker EXASno data available
Financial year endsFY ends End of Decemberno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 17015304560
datesClosing price (adj.)
13.10.201747.41
11.10.201748.91
04.10.201747.99
27.09.201747.08
20.09.201743.40
13.09.201742.11
06.09.201742.35
30.08.201740.76
23.08.201740.39
16.08.201738.66
09.08.201737.25
02.08.201737.89
26.07.201739.65
19.07.201739.14
12.07.201738.81
05.07.201736.07
27.06.201734.09
20.06.201733.27
13.06.201732.33
06.06.201736.59
30.05.201732.65
23.05.201731.90
16.05.201731.95
09.05.201734.87
02.05.201730.97
25.04.201724.89
18.04.201723.99
11.04.201722.87
04.04.201722.69
28.03.201722.75
21.03.201720.14
14.03.201721.04
07.03.201721.56
28.02.201721.52
21.02.201722.41
14.02.201718.90
07.02.201718.47
31.01.201718.95
24.01.201717.54
17.01.201718.57
10.01.201717.57
03.01.201713.41
27.12.201613.99
19.12.201614.01
12.12.201613.88
05.12.201613.90
28.11.201615.19
21.11.201615.05
14.11.201617.60
07.11.201616.41
31.10.201615.58
24.10.201620.12
17.10.201619.73
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
47.41n/a
Market Capitalisation
in million USD
5,646n/a
Enterprise Value
in million USD
5,167n/a
Common Shares Outstanding
as per Jul 24, 2017
119,096,437n/a
Preferred Shares Outstanding
as per Jul 24, 2017
n/a
Average Basic Shares Outstanding
TTM
109,408,500n/a
Average Diluted Shares Outstanding
TTM
n/a
Index Membership
n/a
Business Summary
Exact Sciences Corp operates in the healthcare sector. It is a diagnostics company focused on the early detection and prevention of colorectal cancer.
no data available
Key Financials & Ratios (all figures TTM as per Jun 30, 2017, million USD, full statements further below)
Profit & Loss
Revenues 169n/a
Gross Profit 108n/a
Operating Income -143n/a
EBITDA -130n/a
Net Profit -141n/a
Balance Sheet
Cash and Cash Equivalents 484n/a
Receivables 23n/a
Total Current Assets 526n/a
PP&E 42n/a
Total Assets 583n/a
Accounts Payable 2n/a
Current Debt 0n/a
Total Current Liabilities 31n/a
Long-Term Debt 5n/a
Total Liabilities 42n/a
Total Equity 541n/a
Cash Flow
Depreciation & Amortisation 13n/a
Change in Working Capital -15n/a
Operating Cash Flow -118n/a
Net Change in PP&E and Intangibles -26n/a
Investing Cash Flow -155n/a
Dividends Paid 0n/a
Financing Cash Flow 404n/a
Total Change in Cash 131n/a
Free Cash Flow -171n/a
Profitability Ratios
Gross Margin 64.0%n/a
Operating Margin -84.4%n/a
Net Profit Margin -83.1%n/a
Return on Equity -26.0%n/a
Return on Assets -24.2%n/a
Per Share Figures
Basic EPS -1.29n/a
Diluted EPS n/a
Sales per Share 1.55n/a
Book Value per Share 4.94n/a
FCF per Share -1.56n/a
Dividends per Share 0.00n/a
Price Multiples
Price to Earnings Ratio -36.86n/a
Price to Sales Ratio 30.63n/a
Price to Book Value 9.59n/a
Price to Free Cash Flow -30.41n/a
Valuation Metrics
EV/EBITDA -39.83n/a
EV/Sales 30.51n/a
Book to Market Value 0.10n/a
Other Ratios
Current Ratio 1,681.3%n/a
Liabilities to Equity Ratio 7.8%n/a
Debt to Assets Ratio 0.8%n/a
Profit & Loss StatementP&L data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Revenue
5
5
4
4
4
2
39
99
Sales & Services Revenue
0
0
0
0
0
0
0
0
Financing Revenue
0
0
0
0
0
0
0
0
Other Revenue
0
0
0
0
0
0
0
0
Cost of revenue
0
0
0
0
0
-4
-25
-45
Cost of Goods & Services
0
0
0
0
0
0
0
0
Cost of Financing Revenue
0
0
0
0
0
0
0
0
Cost of Other Revenue
0
0
0
0
0
0
0
0
Gross Profit
5
5
4
4
4
-3
15
54
Other Operating Income
0
0
0
0
0
0
0
0
Operating Expenses
-14
-17
-33
-57
-51
-98
-174
-223
Selling, General & Administrative
-10
-8
-11
-15
-23
-69
-140
-190
Selling & Marketing
0
0
0
0
0
0
0
0
General & Administrative
0
0
0
0
0
0
0
0
Research & Development
-4
-9
-22
-42
-28
-29
-34
-33
Depreciation & Amortization
0
0
0
0
0
0
0
0
Provision For Doubtful Accounts
0
0
0
0
0
0
0
0
Other Operating Expense
0
0
0
0
0
0
0
0
Operating Income (Loss)
-9
-12
-29
-53
-47
-101
-159
-169
Non-Operating Income (Loss)
0
0
0
0
0
0
1
2
Interest Expense, net
0
0
0
0
0
0
0
0
Interest Expense
0
0
0
0
0
0
0
0
Interest Income
0
0
0
0
0
0
0
0
Other Investment Income (Loss)
0
0
0
0
0
1
1
2
Foreign Exchange Gain (Loss)
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates
0
0
0
0
0
0
0
0
Other Non-Operating Income (Loss)
0
0
0
0
0
0
0
0
Pretax Income (Loss), Adjusted
-9
-12
-29
-52
-47
-100
-158
-167
Abnormal Gains (Losses)
0
0
0
0
0
0
0
0
Acquired In-Process R&D
0
0
0
0
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
0
0
0
0
Abnormal Derivatives
0
0
0
0
0
0
0
0
Disposal of Assets
0
0
0
0
0
0
0
0
Early extinguishment of Debt
0
0
0
0
0
0
0
0
Asset Write-Down
0
0
0
0
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
0
0
0
0
Sale of Business
0
0
0
0
0
0
0
0
Legal Settlement
0
0
0
0
0
0
0
0
Restructuring Charges
0
0
0
0
0
0
0
0
Sale of and Unrealized Investments
0
0
0
0
0
0
0
0
Insurance Settlement
0
0
0
0
0
0
0
0
Other Abnormal Items
0
0
0
0
0
0
0
0
Pretax Income (Loss)
-9
-12
-29
-52
-47
-100
-158
-167
Income Tax (Expense) Benefit, net
0
0
0
0
0
0
0
0
Current Income Tax
0
0
0
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
0
0
0
Tax Allowance/Credit
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
0
0
0
0
Income (Loss) from Continuing Operations
-9
-12
-29
-52
-47
-100
-158
-167
Net Extraordinary Gains (Losses)
0
0
0
0
0
0
0
0
Discontinued Operations
0
0
0
0
0
0
0
0
XO & Accounting Charges & Other
0
0
0
0
0
0
0
0
Income (Loss) Including Minority Interest
-9
-12
-29
-52
-47
-100
-158
-167
Minority Interest
0
0
0
0
0
0
0
0
Net Income
-9
-12
-29
-52
-47
-100
-158
-167
Preferred Dividends
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
Net Income Available to Common Shareholders
-9
-12
-29
-52
-47
-100
-158
-167
Remarks
restated on Mar 9, 2012 n/a
calculated values,
restated on Mar 1, 2013 n/a
calculated values,
restated on Feb 28, 2014 n/a
calculated values,
restated on Feb 27, 2015 n/a
calculated values,
restated on Feb 24, 2016 n/a
calculated values,
restated on Feb 21, 2017 n/a
calculated values,
restated on Feb 21, 2017 n/a
calculated values,
restated on Feb 21, 2017 n/a
calculated values,
Balance SheetBS data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Assets
Cash, Cash Equivalents & Short Term Investments
n/a
95
93
108
133
283
307
311
Cash & Cash Equivalents
n/a
79
36
13
13
58
41
49
Short Term Investments
n/a
17
58
95
120
225
266
262
Accounts & Notes Receivable
n/a
0
0
0
0
1
5
9
Accounts Receivable, Net
n/a
0
0
0
0
1
5
9
Notes Receivable, Net
n/a
0
0
0
0
0
0
0
Unbilled Revenues
n/a
0
0
0
0
0
0
0
Inventories
n/a
0
0
0
0
4
7
7
Raw Materials
n/a
0
0
0
0
0
0
0
Work In Process
n/a
0
0
0
0
0
0
0
Finished Goods
n/a
0
0
0
0
0
0
0
Other Inventory
n/a
0
0
0
0
0
0
0
Other Short Term Assets
n/a
0
1
1
2
4
7
7
Prepaid Expenses
n/a
0
1
1
2
4
7
7
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
Assets Held-for-Sale
n/a
0
0
0
0
0
0
0
Deferred Tax Assets
n/a
0
0
0
0
0
0
0
Income Taxes Receivable
n/a
0
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
0
Miscellaneous Short Term Assets
n/a
0
0
0
0
0
0
0
Total Current Assets
n/a
96
94
109
135
292
326
334
Property, Plant & Equipment, Net
n/a
1
3
3
11
20
34
38
Property, Plant & Equipment
n/a
1
3
5
14
26
48
63
Accumulated Depreciation
n/a
0
-1
-2
-3
-6
-14
-25
Long Term Investments & Receivables
n/a
0
0
0
0
0
0
0
Long Term Investments
n/a
0
0
0
0
0
0
0
Long Term Marketable Securities
n/a
0
0
0
0
0
0
0
Long Term Receivables
n/a
0
0
0
0
0
0
0
Other Long Term Assets
n/a
0
0
0
0
1
4
5
Intangible Assets
n/a
0
0
0
0
0
0
0
Goodwill
n/a
0
0
0
0
0
0
0
Other Intangible Assets
n/a
0
0
0
0
0
0
0
Prepaid Expense
n/a
0
0
0
0
0
0
0
Deferred Tax Assets
n/a
0
0
0
0
0
0
0
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
Prepaid Pension Costs
n/a
0
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
0
Investments in Affiliates
n/a
0
0
0
0
0
0
0
Miscellaneous Long Term Assets
n/a
0
0
0
0
1
4
5
Total Noncurrent Assets
n/a
1
3
3
11
21
38
43
Total Assets
n/a
97
97
112
147
313
364
377
Liabilities and owners' equity
Payables & Accruals
n/a
3 3015000
4 3834000
7 6979000
7 6567000
17 16607000
26 25561000
29 28816000
Accounts Payable
n/a
1 1028000
1 765000
4 3652000
1 873000
3 2647000
3 3308000
1 710000
Accrued Taxes
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Interest & Dividends Payable
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Payables & Accruals
n/a
2 1987000
3 3069000
3 3327000
6 5694000
14 13960000
22 22253000
28 28106000
Short Term Debt
n/a
0 0
0 0
0 333000
0 351000
0 360000
0 166000
0 174000
Short Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Current Portion of Long Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Short Term Liabilities
n/a
4 4143000
4 4143000
4 4143000
1 834000
1 554000
1 996000
2 1702000
Deferred Revenue
n/a
4 4143000
4 4143000
4 4143000
0 294000
0 0
0 0
0 0
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Short Term Liabilities
n/a
0 0
0 0
0 0
1 540000
1 554000
1 996000
2 1702000
Total Current Liabilities
n/a
7 7158000
8 7977000
11 11455000
8 7752000
18 17521000
27 26723000
31 30692000
Long Term Debt
n/a
1 1000000
1 1000000
1 1000000
1 1000000
1 1000000
5 4789000
5 4633000
Long Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Long Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Long Term Liabilities
n/a
9 8603000
4 4481000
1 1069000
3 2559000
5 5319000
6 5662000
6 6420000
Accrued Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pension Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pensions
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Post-Retirement Benefits
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Compensation
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Revenue
n/a
9 8582000
4 4439000
0 295000
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
n/a
0 21000
0 42000
1 774000
3 2559000
5 5319000
6 5662000
6 6420000
Total Noncurrent Liabilities
n/a
10 9603000
5 5481000
2 2069000
4 3559000
6 6319000
10 10451000
11 11053000
Total Liabilities
n/a
17 16761000
13 13458000
14 13524000
11 11311000
24 23840000
37 37174000
42 41745000
Preferred Equity
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Share Capital & Additional Paid-In Capital
n/a
273 272902000
305 305333000
373 372762000
456 455950000
710 709906000
906 905899000
1,082 1081534000
Common Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Additional Paid in Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Share Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Treasury Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Retained Earnings
n/a
-193 -193149000
-222 -221824000
-274 -274245000
-321 -320759000
-421 -420807000
-579 -578610000
-746 -745821000
Other Equity
n/a
0 1000
0 -14000
0 78000
0 125000
0 -115000
0 -433000
0 -418000
Equity Before Minority Interest
n/a
80 79754000
83 83495000
99 98595000
135 135316000
289 288984000
327 326856000
335 335295000
Minority Interest
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Total Equity
n/a
80 79754000
83 83495000
99 98595000
135 135316000
289 288984000
327 326856000
335 335295000
Total Liabilities & Equity
n/a
97 96515000
97 96953000
112 112119000
147 146627000
313 312824000
364 364030000
377 377040000
Remarks restated on n/a restated on Mar 9, 2012 n/a restated on Mar 1, 2013 n/a restated on Feb 28, 2014 n/a restated on Feb 27, 2015 n/a restated on Feb 24, 2016 n/a restated on Feb 21, 2017 n/a restated on Jul 25, 2017 n/a
Cash Flow StatementCF data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Net Income/Starting Line
-9
-12
-29
-52
-47
-100
-158
-167
Net Income
0
0
0
0
0
0
0
0
Net Income From Discontinued Operations
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
Depreciation & Amortization
0
0
0
1
1
4
8
12
Non-Cash Items
0
-3
0
3
4
12
18
24
Stock-Based Compensation
0
0
0
0
0
0
0
0
Deferred Income Taxes
0
0
0
0
0
0
0
0
Other Non-Cash Adjustments
0
0
0
0
0
0
0
0
Change in Working Capital
-3
1
1
4
0
3
-2
1
(Increase) Decrease in Accounts Receivable
0
0
0
0
0
0
0
0
(Increase) Decrease in Inventories
0
0
0
0
0
0
0
0
Increase (Decrease) in Accounts Payable
0
0
0
0
0
0
0
0
Increase (Decrease) in Other
0
0
0
0
0
0
0
0
Net Cash From Discontinued Operations (operating)
0
0
0
0
0
0
0
0
Cash from Operating Activities
-13
-13
-27
-45
-40
-81
-134
-130
Change in Fixed Assets & Intangibles
0
-1
-2
-1
-9
-12
-22
-15
Disposition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
Disposition of Fixed Assets
0
0
0
0
0
0
0
0
Disposition of Intangible Assets
0
0
0
0
0
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
Purchase of Fixed Assets
0
0
0
0
0
0
0
0
Acquisition of Intangible Assets
0
0
0
0
0
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
Net Change in Long Term Investment
-2
-14
-41
-38
-26
-105
-43
3
Decrease in Long Term Investment
0
0
0
0
0
0
0
0
Increase in Long Term Investment
0
0
0
0
0
0
0
0
Net Cash From Acquisitions & Divestitures
0
0
0
0
0
0
0
0
Net Cash from Divestitures
0
0
0
0
0
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
0
0
0
0
0
Cash for Joint Ventures
0
0
0
0
0
0
0
0
Net Cash from Other Acquisitions
0
0
0
0
0
0
0
0
Other Investing Activities
0
0
0
0
0
0
0
0
Net Cash From Discontinued Operations (investing)
0
0
0
0
0
0
0
0
Cash from Investing Activities
-3
-15
-43
-38
-35
-117
-65
-12
Dividends Paid
0
0
0
0
0
0
0
0
Cash From (Repayment of) Debt
18
2
0
0
0
2
5
0
Cash From (Repayment of) Short Term Debt, net
0
0
0
0
0
0
0
0
Cash From (Repayment of) Long Term Debt, net
0
0
0
0
0
0
0
0
Repayments of Long Term Debt
0
0
0
0
0
0
0
0
Cash From Long Term Debt
0
0
0
0
0
0
0
0
Cash From (Repurchase of) Equity
15
83
28
61
75
242
177
150
Increase in Capital Stock
15
83
28
61
75
242
177
150
Decrease in Capital Stock
0
0
0
0
0
0
0
0
Other Financing Activities
0
1
0
0
0
0
0
0
Net Cash From Discontinued Operations (financing)
0
0
0
0
0
0
0
0
Cash from Financing Activities
32
85
28
60
75
244
182
150
Net Cash Before Disc. Operations and FX
17
57
-43
-22
0
45
-17
8
Change in Cash from Disc. Operations and Other
0
0
0
0
0
0
0
0
Net Cash Before FX
17
57
-43
-22
0
45
-17
8
Effect of Foreign Exchange Rates
0
0
0
0
0
0
0
0
Net Changes in Cash
17
57
-43
-22
0
45
-17
8
Remarks
restated on Mar 9, 2012 n/a
calculated values,
restated on Mar 1, 2013 n/a
calculated values,
restated on Feb 28, 2014 n/a
calculated values,
restated on Feb 27, 2015 n/a
calculated values,
restated on Feb 24, 2016 n/a
calculated values,
restated on Feb 21, 2017 n/a
calculated values,
restated on Feb 21, 2017 n/a
calculated values,
restated on Feb 21, 2017 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
Sumo